Both in Biotechnology
REGENXBIO vs Allogene Therapeutics
Over the past year RGNX returned −40.3% and ALLO returned −7.6%; their daily moves had a correlation of 0.36.
RGNX −40.3% ALLO −7.6%Growth of $1, one year, split-adjusted
| Metric | RGNX | ALLO |
|---|---|---|
| Price | $7.16 | $1.09 |
| Market cap | $472.7M | $376.6M |
| Today | −0.56% | −7.63% |
| 1 month | −3.6% | −27.3% |
| 6 months | −23.7% | −51.8% |
| Year to date | −50.3% | −20.4% |
| 1 year | −44.1% | −9.9% |
| Revenue growth (YoY) | +405.7% | — |
| Gross margin | 99.0% | 100.0% |
| Net margin | 21.0% | −919.8% |
| P/E (TTM) | — | — |
| Price / sales | 2.7× | 81.2× |
| Net cash | $105.5M | $332.6M |
| Dividend yield | — | — |
| Volatility (60d) | 86.1% | 55.0% |
| Short % of float | 19.4% | 19.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).